Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Intrathecal Nicardipine for Vasospasm in Subarachnoid Hemorrhage
NCT07246629Phase 4Not yet recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2027
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nicardipine in subarachnoid hemorrhage (SAH), sponsored by Wake Forest University Health Sciences. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
nicardipine
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT07246629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07246629.